跳至主要内容
临床试验/NCT00949338
NCT00949338已完成不适用

A Randomised Trial Comparing The Bladder Volume Consistency Achieved With Two Bladder-Filling Protocols in Prostate Conformal Radiotherapy

Cancer Trials Ireland1 个研究点 分布在 1 个国家目标入组 183 人开始时间: 2006年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
183
试验地点
1
主要终点
Consistency of bladder volumes

研究概览

简要总结

RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Having a full bladder may improve the effectiveness of radiation therapy to the bladder. It is not yet known which set of bladder-filling instructions is more effective in helping patients keep their bladder full during radiation therapy.

PURPOSE: This randomized clinical trial is comparing two sets of bladder-filling instructions in treating patients with prostate cancer undergoing radiation therapy.

详细描述

OBJECTIVES:

Primary

  • To compare the consistency in bladder volumes in patients with prostate cancer undergoing conformal radiotherapy, when randomized to one of two sets of bladder-filling instructions.

Secondary

  • To compare the incidence of acute and late genitourinary and gastrointestinal toxicity in patients treated with these methods.
  • To determine patient satisfaction with the bladder-filling instructions.
  • To determine satisfaction of bladder-filling protocols amongst radiation therapists and doctors.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •DISEASE CHARACTERISTICS:
  • •Diagnosis of prostate cancer
  • •Undergoing a radical course of radiotherapy
  • •Planned treatment in the supine position
  • •PATIENT CHARACTERISTICS:
  • •Karnofsky performance status 60-100%
  • •No history of urinary incontinence or urinary catheterization
  • •No evidence of any other significant clinical disorder or laboratory finding that makes it undesirable for the patient to participate in the trial or if it is felt by the research/medical team that the patient may not be able to comply with the protocol
  • •Fertile patients must use effective contraception
  • •PRIOR CONCURRENT THERAPY:
  • •See Disease Characteristics
  • •No previous surgery for urinary conditions, except transurethral resection of the prostate (TURP)
  • •Prior transrectal ultrasound (TRUS) allowed

排除标准

  • 未提供

研究组 & 干预措施

Arm II

Experimental

Patients empty their bladders and consume 3 cups of water 30 minutes before undergoing radiotherapy. Patients also undergo bladder volume measurements using a BVI periodically during treatment.

干预措施: pre-procedural preparation (Procedure)

Arm I

Active Comparator

Patients empty their bladders and consume 6 cups of water 30 minutes before undergoing radiotherapy. Patients also undergo bladder volume measurements using a bladder volume instrument (BVI) periodically during treatment.

干预措施: pre-procedural preparation (Procedure)

结局指标

主要结局

Consistency of bladder volumes

时间窗: 2011

次要结局

  • Incidence of acute and late genitourinary and gastrointestinal toxicity(4 years)
  • Patient satisfaction with bladder-filling instructions(2011)
  • Staff satisfaction of bladder-filling protocols(2011)

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

已完成
3 期
Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate CancerProstate Cancer
NCT00849082European Organisation for Research and Treatment of Cancer - EORTC
已完成
不适用
Less to Hold - A Comparison of Bladder Toxicities (Side Effects) in Patients Undergoing Prostate Radiotherapy Between Patients Treated With Empty Bladder and Those on a Drinking Protocol.Radiotherapy Side EffectProstate Cancer
NCT03832803Lancashire Teaching Hospitals NHS Foundation Trust50
撤回
不适用
Radiotherapy Treatment Planning Comparison Using SBRT-PATHY (Photons) Versus CARBON-PATHY for Unresectable Bulky TumorsCancer
NCT06390657EBG MedAustron GmbH20
Unknown
1 期
3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the BladderBladder Cancer
NCT01124682Institute of Cancer Research, United Kingdom60
终止
1 期
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCCSalivary Gland Squamous Cell CarcinomaStage III Salivary Gland CancerStage III Squamous Cell Carcinoma of the OropharynxStage IV Verrucous Carcinoma of the Oral CavityStage III Squamous Cell Carcinoma of the Lip and Oral CavityStage IV Salivary Gland CancerStage IV Squamous Cell Carcinoma of the OropharynxStage III Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the Lip and Oral CavityStage II Salivary Gland CancerStage II Squamous Cell Carcinoma of the Lip and Oral CavityStage II Squamous Cell Carcinoma of the HypopharynxStage II Squamous Cell Carcinoma of the OropharynxStage II Verrucous Carcinoma of the Oral CavityStage III Verrucous Carcinoma of the Oral Cavity
NCT01283178Virginia Commonwealth University3